Aarti Drugs Financials

AARTIDRUGS   449.25  5.50  1.21%   
We suggest to use Aarti Drugs Limited fundamental analysis to see if markets are presently undervaluing or overvaluing the company. Put another way, you can use it to find out if Aarti Drugs Limited is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We are able to break down and analyze data for twenty-eight available fundamental indicators for Aarti Drugs Limited, which can be compared to its peers. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Aarti Drugs to be traded at 435.77 in 90 days. Key indicators impacting Aarti Drugs' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income7.5 B7.1 B
Sufficiently Up
Slightly volatile
  
Understanding current and past Aarti Drugs Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aarti Drugs' financial statements are interrelated, with each one affecting the others. For example, an increase in Aarti Drugs' assets may result in an increase in income on the income statement.

Aarti Drugs Stock Summary

Aarti Drugs competes with Kingfa Science, Rico Auto, GACM Technologies, COSMO FIRST, and Tribhovandas Bhimji. Aarti Drugs is entity of India. It is traded as Stock on NSE exchange.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentIndia Stock View All
ExchangeNational Stock Exchange of India
ISININE767A01016
Business AddressMahendra Industrial Estate,
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.aartidrugs.co.in
Phone91 22 2401 9025
You should never invest in Aarti Drugs without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Aarti Stock, because this is throwing your money away. Analyzing the key information contained in Aarti Drugs' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Aarti Drugs Key Financial Ratios

There are many critical financial ratios that Aarti Drugs' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Aarti Drugs Limited reports annually and quarterly.

Aarti Drugs Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets15.8B17.7B22.1B24.2B24.3B12.7B
Net Debt3.8B3.4B5.2B6.0B5.6B4.2B
Cash67.7M88.1M216.1M89.6M67.4M65.7M
Net Receivables5.7B5.6B7.6B8.6B7.1B4.2B
Inventory3.3B4.2B5.3B5.2B5.0B2.5B
Total Liab9.2B8.5B11.7B12.3B11.5B7.6B
Total Current Assets9.0B10.6B13.9B14.9B13.2B7.1B
Retained Earnings5.9B7.5B8.8B10.2B11.6B12.1B
Accounts Payable3.3B3.3B4.7B4.8B4.5B2.9B
Other Assets2K11.5M1K72.6M236.7M0.95
Short Term Debt2.0B2.0B4.0B4.0B2.9B3.2B
Intangible Assets14.9M2.6M1.5M7.9M368.2M386.7M
Other Liab1.1B1.1B912.2M906.7M1.0B949.0M
Net Tangible Assets6.5B9.1B10.4B11.9B13.7B14.4B
Long Term Debt1.8B1.5B1.4B2.0B2.8B2.0B
Short Long Term Debt2.0B1.6B4.0B4.0B2.9B2.8B
Long Term Debt Total1.9B1.5B1.4B2.1B1.8B1.5B
Net Invested Capital10.3B12.2B15.7B18.0B18.4B15.0B
Net Working Capital2.7B4.6B4.5B5.6B5.3B4.1B

Aarti Drugs Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense337.3M229.6M207.5M332.9M378.9M315.0M
Total Revenue18.1B21.5B24.9B27.2B25.3B13.7B
Gross Profit4.0B6.0B5.0B8.3B8.3B8.7B
Operating Income2.1B3.9B2.9B2.6B7.1B7.5B
Ebit2.2B4.0B2.9B2.6B2.7B1.7B
Ebitda2.7B4.5B3.4B3.1B3.2B2.0B
Cost Of Revenue14.0B15.5B19.8B18.9B17.0B10.3B
Income Before Tax1.9B3.7B2.7B2.2B2.4B1.3B
Net Income1.4B2.8B2.1B1.7B1.7B969.9M
Income Tax Expense438.9M886.2M649.6M578.2M639.4M358.6M
Research Development87.4M86.0M66.1M77.5M120.2M70.5M
Tax Provision438.9M886.2M649.6M578.2M639.4M566.4M
Interest Income305.7M229.6M207.5M332.9M299.6M256.1M
Net Interest Income(363.0M)(229.6M)(207.5M)(332.9M)(335.2M)(352.0M)

Aarti Drugs Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(786.9M)(891.8M)(1.1B)58.2M342.5M359.6M
Change In Cash21.3M20.4M128.0M(132.3M)(7.6M)(7.2M)
Free Cash Flow2.0B667.2M(823.4M)(304.7M)1.0B1.1B
Depreciation487.5M498.8M500.5M503.2M514.5M367.1M
Other Non Cash Items(27.9M)(779.6M)(630.2M)(248.4M)332.7M349.4M
Dividends Paid70.3M232.1M95.1M94M92.7M104.7M
Capital Expenditures479.9M881.3M1.5B1.6B2.3B2.4B
Net Income1.9B3.7B2.7B2.2B1.7B1.3B
End Period Cash Flow67.7M88.1M216.1M83.8M67.4M68.2M
Net Borrowings(1.5B)(349.7M)2.0B613.7M705.8M741.1M
Change To Netincome411.0M106.5M19.0M330.3M297.2M284.1M

Aarti Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aarti Drugs's current stock value. Our valuation model uses many indicators to compare Aarti Drugs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aarti Drugs competition to find correlations between indicators driving Aarti Drugs's intrinsic value. More Info.
Aarti Drugs Limited is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.50  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Aarti Drugs Limited is roughly  1.98 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aarti Drugs' earnings, one of the primary drivers of an investment's value.

Aarti Drugs Limited Systematic Risk

Aarti Drugs' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aarti Drugs volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Aarti Drugs Limited correlated with the market. If Beta is less than 0 Aarti Drugs generally moves in the opposite direction as compared to the market. If Aarti Drugs Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aarti Drugs Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aarti Drugs is generally in the same direction as the market. If Beta > 1 Aarti Drugs moves generally in the same direction as, but more than the movement of the benchmark.

Aarti Drugs Limited Total Assets Over Time

Aarti Drugs Thematic Clasifications

Aarti Drugs Limited is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
DrugsView
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas

Aarti Drugs November 23, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Aarti Drugs help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aarti Drugs Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aarti Drugs Limited based on widely used predictive technical indicators. In general, we focus on analyzing Aarti Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aarti Drugs's daily price indicators and compare them against related drivers.

Additional Tools for Aarti Stock Analysis

When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.